Radiolabelled Insulin
    2.
    发明申请
    Radiolabelled Insulin 审中-公开
    放射性标记胰岛素

    公开(公告)号:US20080213174A1

    公开(公告)日:2008-09-04

    申请号:US11575158

    申请日:2005-09-13

    IPC分类号: A61K51/08 C07K14/62

    CPC分类号: A61K51/088

    摘要: The invention relates to in vivo imaging agents, specifically radiolabelled insulin derivatives of formula (III); wherein X is —CO—NH—, —NH—, —O—, —NHCONH—, or —NHCSNH—, and is preferably —CO—NH—, —NH— or —O—; Y is H, alkyl or aryl substituents; R* is a radiolabel moiety suitable for detection by SPECT or PET; and methods for preparing the same as well as their use in in vivo imaging methods.

    摘要翻译: 本发明涉及体内成像剂,特别是式(III)的放射性标记的胰岛素衍生物; 其中X是-CO-NH-,-NH-,-O-,-NHCONH-或-NHCSNH-,优选为-CO-NH-,-NH-或-O-; Y是H,烷基或芳基取代基; R *是适于通过SPECT或PET检测的放射性标记部分; 及其制备方法以及它们在体内成像方法中的应用。

    CONTRAST AGENTS
    3.
    发明申请
    CONTRAST AGENTS 失效
    对比剂

    公开(公告)号:US20100111865A1

    公开(公告)日:2010-05-06

    申请号:US12519183

    申请日:2007-12-19

    IPC分类号: A61K49/00 C07K4/00 A61K38/00

    摘要: The present invention provides novel compounds and pharmaceutical compositions containing such compounds, wherein the compounds have affinity for proteoglycans. The compounds comprise an amino acid based core unit linked to positively charged moieties. The compounds further comprise at least one imaging moiety detectable in in vivo imaging making the compounds useful as diagnostic contrast agents for imaging of proteoglycans, such as heparan sulphate proteoglycans.

    摘要翻译: 本发明提供含有这些化合物的新化合物和药物组合物,其中化合物对蛋白聚糖具有亲和力。 所述化合物包含与带正电荷部分连接的基于氨基酸的核心单元。 所述化合物还包含在体内成像中可检测的至少一个成像部分,使得该化合物可用作蛋白聚糖成像的诊断造影剂,例如硫酸乙酰肝素蛋白聚糖。

    RADIOFLORINATION METHODS
    6.
    发明申请
    RADIOFLORINATION METHODS 审中-公开
    放射学方法

    公开(公告)号:US20080274052A1

    公开(公告)日:2008-11-06

    申请号:US12098537

    申请日:2008-04-07

    CPC分类号: C07B59/008

    摘要: The present invention relates to methods and reagents for [18F]-fluorination, particularly of peptides. The resultant 18F-labelled compounds are useful as radiopharmaceuticals, specifically for use in Positron Emission Tomography (PET). Thus, a compound of formula 18F-(Linker)-SH, such as a compound of formula (IV), (V), or (VI): may be reacted with an activated peptide as a means for 18F-labelling.

    摘要翻译: 本发明涉及[F 18 F] - 氟化,特别是肽的方法和试剂。 所得的18 F标记的化合物可用作放射性药物,特别用于正电子发射断层扫描(PET)。 因此,式(Ⅳ),(Ⅴ)或(Ⅵ)化合物可以将式(ⅩⅥ)F-(接头)-SH的化合物与活化肽作为 用于 18 F标签的方法。

    Radiofluorination methods
    7.
    发明授权
    Radiofluorination methods 失效
    放射性氟化方法

    公开(公告)号:US07368474B2

    公开(公告)日:2008-05-06

    申请号:US10508682

    申请日:2003-03-20

    IPC分类号: A61K51/08 A61K101/02

    CPC分类号: C07B59/008

    摘要: The present invention relates to methods and reagents for [18F]-fluorination, particularly of peptides. The resultant 18F-labelled compounds are useful as radiopharmaceuticals, specifically for use in Positron Emission Tomography (PET). Thus, a compound of formula 18F-(Linker)-SH, such as a compound of formula (IV), (V), or (VI): 18F—(CH2CH2O)n—(CH2)m—SH   (IV) 18F—(CH2)p—SH   (V) may be reacted with an activated peptide as a means for 18F-labelling.

    摘要翻译: 本发明涉及[F 18 F] - 氟化,特别是肽的方法和试剂。 所得的18 F标记的化合物可用作放射性药物,特别用于正电子发射断层扫描(PET)。 因此,通式(IV)的化合物,如式(IV),(V)或(VI)的化合物: “在线公式”end =“lead”?> 18 F-(CH 2 2 CH 2 O) β-H(IV)<βin-line-formula description =“In-line Formulas”end =“tail”?> < ?in-line-formula description =“In-line Formulas”end =“lead”?> 18 F-(CH 2) -SH(V)<βin-line-formula description =“In-line Formulas”end =“tail”?>可与活化肽反应,作为标记的标记。

    Radiofluorination methods
    8.
    发明申请
    Radiofluorination methods 失效
    放射性氟化方法

    公开(公告)号:US20050142061A1

    公开(公告)日:2005-06-30

    申请号:US10508682

    申请日:2003-03-20

    CPC分类号: C07B59/008

    摘要: The present invention relates to methods and reagents for [18F]-fluorination, particularly of peptides. The resultant 18F-labelled compounds are useful as radiopharmaceuticals, specifically for use in Positron Emission Tomography (PET). Thus, a compound of formula 18F-(Linker)-SH, such as a compound of formula (IV), (V), or (VI): 18F—(CH2CH2O)n—(CH2)m—SH   (IV) 18F—(CH2)p—SH   (V) may be reacted with an activated peptide as a means for 18F-labelling.

    摘要翻译: 本发明涉及[F 18 F] - 氟化,特别是肽的方法和试剂。 所得的18 F标记的化合物可用作放射性药物,特别用于正电子发射断层扫描(PET)。 因此,通式(IV)的化合物,如式(IV),(V)或(VI)的化合物: “在线公式”end =“lead”?> 18 F-(CH 2 2 CH 2 O) β-H(IV)<βin-line-formula description =“In-line Formulas”end =“tail”?> < ?in-line-formula description =“In-line Formulas”end =“lead”?> 18 F-(CH 2) -SH(V)<βin-line-formula description =“In-line Formulas”end =“tail”?>可与活化肽反应,作为标记的标记。

    Contrast agents
    9.
    发明授权
    Contrast agents 失效
    对比剂

    公开(公告)号:US08273325B2

    公开(公告)日:2012-09-25

    申请号:US12519183

    申请日:2007-12-19

    IPC分类号: A61K51/00 A61M36/14

    摘要: The present invention provides novel compounds and pharmaceutical compositions containing such compounds, wherein the compounds have affinity for proteoglycans. The compounds comprise an amino acid based core unit linked to positively charged moieties. The compounds further comprise at least one imaging moiety detectable in in vivo imaging making the compounds useful as diagnostic contrast agents for imaging of proteoglycans, such as heparan sulphate proteoglycans.

    摘要翻译: 本发明提供含有这些化合物的新化合物和药物组合物,其中化合物对蛋白聚糖具有亲和力。 所述化合物包含与带正电荷部分连接的基于氨基酸的核心单元。 所述化合物还包含在体内成像中可检测的至少一个成像部分,使得该化合物可用作蛋白聚糖成像的诊断造影剂,例如硫酸乙酰肝素蛋白聚糖。